Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru the end of 2024, so you can switch back as our improvements continue.
Legislation Quick Search
06/15/2024 07:09 AM
Pennsylvania House of Representatives
https://www.legis.state.pa.us/cfdocs/Legis/CSM/showMemoPublic.cfm?chamber=H&SPick=20150&cosponId=18392
Share:
Home / House Co-Sponsorship Memoranda

House Co-Sponsorship Memoranda

Subscribe to PaLegis Notifications
NEW!

Subscribe to receive notifications of new Co-Sponsorship Memos circulated

By Member | By Date | Keyword Search


House of Representatives
Session of 2015 - 2016 Regular Session

MEMORANDUM

Posted: May 20, 2015 02:21 PM
From: Representative Gene DiGirolamo
To: All House members
Subject: Misuse and Diversion of Buprenorphine (Suboxone) Legislation
 
In the near future I plan to introduce two bills to address the misuse and diversion of buprenorphine, a drug known by the brand names Suboxone and Zubsolv. Initially launched 10 years ago as an opioid drug to treat addiction, buprenorphine has become an abused drug itself. In fact, it is all over the streets across the Commonwealth, including its availability in jails where it has been smuggled in under postage stamps.

The legislative package will do the following:
  • Add buprenorphine to the Methadone Death and Incident Review Law.
  • Require those doctors who prescribe buprenorphine to check the Prescription Monitoring Database every time they write a prescription for buprenorphine.
I encourage you to join me in cosponsorship of these important bills.



Introduced as HB1294